Historique
Bulletin de Périodique
Annals of the New York Academy of Sciences , Vol.965 - June 2002 - Cellular and molecular mechanisms of drugs of abuse II : Cocaine, substituted amphetamines, GHB, and opiates
Auteur(s) :
ALI, S. F. (Éditeur scientifique)
Paru le :
01/06/2002
Année
2002
Page(s) :
537 p.
Langue(s) :
Anglais
Domaine :
Drogues illicites / Illicit drugs
Thésaurus mots-clés
BIOCHIMIE
;
PHARMACOLOGIE
;
COCAINE
;
AMPHETAMINE
;
GHB
;
OPIACES
;
GENETIQUE
;
NEUROBIOLOGIE
;
TOXICITE
;
GBL
;
MDMA-ECSTASY
;
CERVEAU
Note générale :
ISBN : 978-1-57331-409-9
Note de contenu :
CONTENTS:
PART I. Gene expression/molecular mechanisms of drug addiction
• Identification of chronic cocaine-induced gene expression through dopamine d1 receptors by using cDNA microarrays. Zhang J., Zhang D., Xu M., p. 1-9.
• Gene expression profiles in the brain from phencyclidine-treated mouse by using DNA microarray. Toyooka K., Usui M., Washiyama K., Kumanishi T., Takahashi Y., p. 10-20.
• A single dose of methamphetamine rescues the blunted dopamine D(1)-receptor activity in the neocortex of D(2)- and D(3)-receptor knockout mice. Schmauss C., Glickstein S.B., Adlersberg M., Hsiung S.C., Tamir H., p. 21-27.
• Ibogaine signals addiction genes and methamphetamine alteration of long-term potentiation. Onaivi E.S., Ali S.F., Chirwa S.S., Zwiller J., Thiriet N., Akinshola B.E., et al., p. 28-46.
• The nitric oxide releasing agent sodium nitroprusside modulates cocaine-induced immediate early gene expression in rat brain. Thiriet N., Aunis D., Zwiller J., p. 47-54.
• Gene expression related to synaptogenesis, neuritogenesis, and MAP kinase in behavioral sensitization to psychostimulants. Ujike H., Takaki M., Kodama M., Kuroda S., p. 55-67.
• Prenatal exposure to methamphetamine in the rat: ontogeny of tyrosine hydroxylase mRNA expression in mesencephalic dopaminergic neurons. Gomes-da-Silva J., Perez-Rosado A., de Miguel R., Fernandez-Ruiz J., Silva M.C., Tavares M.A., p. 68-77.
• Neuroadaptive changes in NMDAR1 gene expression after extinction of cocaine self-administration. Crespo J.A., Oliva J.M., Ghasemzadeh M.B., Kalivas P.W., Ambrosio E., p. 78-91.
PART II. Drugs of abuse and medication development: cocaine, meth, opiates
• Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence. Baumann M.H., Phillips J.M., Ayestas M.A., Ali S.F., Rice K.C., Rothman R.B., p. 92-108.
• Appetite suppressants as agonist substitution therapies for stimulant dependence. Rothman R.B., Blough B.E., Baumann M.H., p. 109-126.
PART III. Role of neurochemistry in drugs of abuse: neurodegeneration, neuroprotection, and neuroadaptation
• Behavioral consequences of methamphetamine-induced neurotoxicity in mice: relevance to the psychopathology of methamphetamine addiction. Itzhak Y., Ali S.F., p. 127-135.
• Estrogen, anti-estrogen, and gender: differences in methamphetamine neurotoxicity. Dluzen D.E., McDermott J.L., p. 136-156.
• Effects of cocaine administration on VTA cell activity in response to prefrontal cortex stimulation. Almodovar-Fabregas L.J., Segarra O., Colon N., Dones J.G., Mercado M., Mejias-Aponte C.A., et al., p. 157-171.
• Adaptation to repeated cocaine administration in rats. Binienda Z.K., Pereira F., Alper K., Slikker W., Jr., Ali S.F., p. 172-179.
• Neurochemical changes and neurotoxic effects of an acute treatment with sydnocarb, a novel psychostimulant: comparison with D-amphetamine. Bashkatova V., Mathieu-Kia A.M., Durand C., Penit-Soria J., p. 180-192.
• Effects of acute toxic doses of psychostimulants on extracellular levels of excitatory amino acids and taurine in rats: comparison of d-amphetamine and sydnocarb. Anderzhanova E., Rayevsky K.S., Saransaari P., Riitamaa E., Oja S.S., p. 193-203.
• Methamphetamine-induced dopaminergic neurotoxicity and production of peroxynitrite are potentiated in nerve growth factor differentiated pheochromocytoma 12 cells. Imam S.Z., Newport G.D., Duhart H.M., Islam F., Slikker W., Jr., Ali S.F., p. 204-213.
• Neurotoxicity of diethylpropion: neurochemical and behavioral findings in rats. Galvan-Arzate S., Santamaria A., p. 214-224.
• The protective role of L-carnitine against neurotoxicity evoked by drug of abuse, methamphetamine, could be related to mitochondrial dysfunction. Virmani A., Gaetani F., Imam S., Binienda Z., Ali S., p. 225-232.
• A single exposure to restraint stress induces behavioral and neurochemical sensitization to stimulating effects of amphetamine: involvement of NMDA receptors. Pacchioni A.M., Gioino G., Assis A., Cancela L.M., p. 233-246.
PART IV. Specific neuronal markers in substituted amphetamine-induced neurotoxicity
• Ontogeny of neurokinin-1 receptor mediation of methamphetamine neurotoxicity in the striatum of the mouse brain. Yu J., Allison S., Ibrahim D., Cadet J.L., Angulo J.A., p. 247-253.
• Morphological and biochemical evidence that apomorphine rescues striatal dopamine terminals and prevents methamphetamine toxicity. Battaglia G., Gesi M., Lenzi P., Busceti C.L., Soldani P., Orzi F., et al., p. 254-266.
• Neurokinin receptors modulate the neurochemical actions of cocaine. Noailles P.A., Angulo J.A., p. 267-273.
• Calpain upregulation and neuron death in spinal cord of MPTP-induced parkinsonism in mice. Chera B., Schaecher K.E., Rocchini A., Imam S.Z., Ray S.K., Ali S.F., et al., p. 274-280.
PART V. Drugs of abuse: cocaine, methamphetamine, toulene, alcohol, and nicotine
• Abused inhalants and central reward pathways: electrophysiological and behavioral studies in the rat. Riegel A.C., French E.D., p. 281-291.
• Factors for susceptibility to episode recurrence in spontaneous recurrence of methamphetamine psychosis. Yui K., Ikemoto S., Goto K., p. 292-304.
• Environmental chemical compounds could induce sensitization to drugs of abuse. Duffard R., Evangelista de Duffard A.M., p. 305-313.
• Increased sensitivity in dopamine D(2)-like brain receptors from 2,4-dichlorophenoxyacetic acid (2,4-D)-exposed and amphetamine-challenged rats. Bortolozzi A., Duffard R., Antonelli M., Evangelista de Duffard A.M., p. 314-323.
• Developmental expression of the beta-amyloid precursor protein and heat-shock protein 70 in the cerebral hemisphere region of the rat brain. Lahiri D.K., Nall C., Chen D., Zaphiriou M., Morgan C., Nurnberger J.I., Sr., p. 324-333.
• Alcohol exposure during adulthood induces neuronal and astroglial alterations in the hippocampal CA-1 area. Tagliaferro P., Vega M.D., Evrard S.G., Ramos A.J., Brusco A., p. 334-342.
• Effects of chronic maternal ethanol exposure on hippocampal and striatal morphology in offspring. Ramos A.J., Evrard S.G., Tagliaferro P., Tricarico M.V., Brusco A., p. 343-353.
• Brain regions mediating the discriminative stimulus effects of nicotine in rats. Miyata H., Ando K., Yanagita T., p. 354-363.
• Nicotine reduces the secretion of Alzheimer's beta-amyloid precursor protein containing beta-amyloid peptide in the rat without altering synaptic proteins. Lahiri D.K., Utsuki T., Chen D., Farlow M.R., Shoaib M., Ingram D.K., et al., p. 364-372.
PART VI. MDMA neurotoxicity
• Serotonergic neurotoxicity of MDMA (ecstasy) in the developing rat brain. Meyer J.S., Ali S.F., p. 373-380.
• Striatal postsynaptic ultrastructural alterations following methylenedioxymethamphetamine administration. Fornai F., Gesi M., Lenzi P., Ferrucci M., Pellegrini A., Ruggieri S., et al., p. 381-398.
• Action of MDMA (ecstasy) and its metabolites on arginine vasopressin release. Fallon J.K., Shah D., Kicman A.T., Hutt A.J., Henry J.A., Cowan D.A., et al., p. 399-409.
• Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study. Gough B., Imam S.Z., Blough B., Slikker W., Jr., Ali S.F., p. 410-420.
• Cell-mediated immune response in MDMA users after repeated dose administration: studies in controlled versus noncontrolled settings. Pacifici R., Zuccaro P., Farre M., Pichini S., Di Carlo S., Roset P.N., et al., p. 421-433.
PART VII. Drugs of abuse, imaging brain structure, and function
• Methylphenidate-evoked potentiation of extracellular dopamine in the brain of adolescents with premature birth: correlation with attentional deficit. Rosa Neto P., Lou H., Cumming P., Pryds O., Gjedde A., p. 434-439.
• The competition between endogenous dopamine and radioligands for specific binding to dopamine receptors. Cumming P., Wong D.F., Dannals R.F., Gillings N., Hilton J., Scheffel U., et al., p. 440-450.
PART VIII. GHB, GBL, BD: Behavior, biochemistry, and pharmacokinetics
• Repeated administration of gamma-hydroxybutyric acid (GHB) to mice: assessment of the sedative and rewarding effects of GHB. Itzhak Y., Ali S.F., p. 451-460.
• Enzyme and receptor antagonists for preventing toxicity from the gamma-hydroxybutyric acid precursor 1,4-butanediol in CD-1 mice. Quang L.S., Desai M.C., Kraner J.C., Shannon M.W., Woolf A.D., Maher T.J., p. 461-472.
PART IX. Drugs of abuse: Heroin and opiates - from animal to human
• Cell signaling as a target and underlying mechanism for neurobehavioral teratogenesis. Yanai J., Vatury O., Slotkin T.A., p. 473-478.
• Nitric oxide production and nitric oxide synthase expression in platelets from heroin abusers before and after ultrarapid detoxification. Batista A., Macedo T., Tavares P., Ribeiro C.F., Relvas J., Gomes P., et al., p. 479-486.
• Toxic effects of opioid and stimulant drugs on undifferentiated PC12 cells. Oliveira M.T., Rego A.C., Morgadinho M.T., Macedo T.R., Oliveira C.R., p. 487-496.
• Recombinant mu-delta receptor as a marker of opiate abuse. Dambinova S.A., Izykenova G.A., p. 497-514.
PART X. Perinatal exposure of cocaine and methamphetamine: neurobehavioral and neurochemical outcome
• Neonatal exposure to cocaine: altered dopamine levels in the amygdala and behavioral outcomes in the developing rat. Summavielle T., Magalhaes A., Castro-Vale I., de Sousa L., Tavares M.A., p. 515-521.
• Structural and functional cellular alterations underlying the toxicity of methamphetamine in rat retina and prefrontal cortex. Prudencio C., Abrantes B., Lopes I., Tavares M.A., p. 522-528.
• Postnatal cocaine exposure: effects on behavior of rats in forced swim test. Magalhaes A., Tavares M.A., de Sousa L., p. 529-534.
PART I. Gene expression/molecular mechanisms of drug addiction
• Identification of chronic cocaine-induced gene expression through dopamine d1 receptors by using cDNA microarrays. Zhang J., Zhang D., Xu M., p. 1-9.
• Gene expression profiles in the brain from phencyclidine-treated mouse by using DNA microarray. Toyooka K., Usui M., Washiyama K., Kumanishi T., Takahashi Y., p. 10-20.
• A single dose of methamphetamine rescues the blunted dopamine D(1)-receptor activity in the neocortex of D(2)- and D(3)-receptor knockout mice. Schmauss C., Glickstein S.B., Adlersberg M., Hsiung S.C., Tamir H., p. 21-27.
• Ibogaine signals addiction genes and methamphetamine alteration of long-term potentiation. Onaivi E.S., Ali S.F., Chirwa S.S., Zwiller J., Thiriet N., Akinshola B.E., et al., p. 28-46.
• The nitric oxide releasing agent sodium nitroprusside modulates cocaine-induced immediate early gene expression in rat brain. Thiriet N., Aunis D., Zwiller J., p. 47-54.
• Gene expression related to synaptogenesis, neuritogenesis, and MAP kinase in behavioral sensitization to psychostimulants. Ujike H., Takaki M., Kodama M., Kuroda S., p. 55-67.
• Prenatal exposure to methamphetamine in the rat: ontogeny of tyrosine hydroxylase mRNA expression in mesencephalic dopaminergic neurons. Gomes-da-Silva J., Perez-Rosado A., de Miguel R., Fernandez-Ruiz J., Silva M.C., Tavares M.A., p. 68-77.
• Neuroadaptive changes in NMDAR1 gene expression after extinction of cocaine self-administration. Crespo J.A., Oliva J.M., Ghasemzadeh M.B., Kalivas P.W., Ambrosio E., p. 78-91.
PART II. Drugs of abuse and medication development: cocaine, meth, opiates
• Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence. Baumann M.H., Phillips J.M., Ayestas M.A., Ali S.F., Rice K.C., Rothman R.B., p. 92-108.
• Appetite suppressants as agonist substitution therapies for stimulant dependence. Rothman R.B., Blough B.E., Baumann M.H., p. 109-126.
PART III. Role of neurochemistry in drugs of abuse: neurodegeneration, neuroprotection, and neuroadaptation
• Behavioral consequences of methamphetamine-induced neurotoxicity in mice: relevance to the psychopathology of methamphetamine addiction. Itzhak Y., Ali S.F., p. 127-135.
• Estrogen, anti-estrogen, and gender: differences in methamphetamine neurotoxicity. Dluzen D.E., McDermott J.L., p. 136-156.
• Effects of cocaine administration on VTA cell activity in response to prefrontal cortex stimulation. Almodovar-Fabregas L.J., Segarra O., Colon N., Dones J.G., Mercado M., Mejias-Aponte C.A., et al., p. 157-171.
• Adaptation to repeated cocaine administration in rats. Binienda Z.K., Pereira F., Alper K., Slikker W., Jr., Ali S.F., p. 172-179.
• Neurochemical changes and neurotoxic effects of an acute treatment with sydnocarb, a novel psychostimulant: comparison with D-amphetamine. Bashkatova V., Mathieu-Kia A.M., Durand C., Penit-Soria J., p. 180-192.
• Effects of acute toxic doses of psychostimulants on extracellular levels of excitatory amino acids and taurine in rats: comparison of d-amphetamine and sydnocarb. Anderzhanova E., Rayevsky K.S., Saransaari P., Riitamaa E., Oja S.S., p. 193-203.
• Methamphetamine-induced dopaminergic neurotoxicity and production of peroxynitrite are potentiated in nerve growth factor differentiated pheochromocytoma 12 cells. Imam S.Z., Newport G.D., Duhart H.M., Islam F., Slikker W., Jr., Ali S.F., p. 204-213.
• Neurotoxicity of diethylpropion: neurochemical and behavioral findings in rats. Galvan-Arzate S., Santamaria A., p. 214-224.
• The protective role of L-carnitine against neurotoxicity evoked by drug of abuse, methamphetamine, could be related to mitochondrial dysfunction. Virmani A., Gaetani F., Imam S., Binienda Z., Ali S., p. 225-232.
• A single exposure to restraint stress induces behavioral and neurochemical sensitization to stimulating effects of amphetamine: involvement of NMDA receptors. Pacchioni A.M., Gioino G., Assis A., Cancela L.M., p. 233-246.
PART IV. Specific neuronal markers in substituted amphetamine-induced neurotoxicity
• Ontogeny of neurokinin-1 receptor mediation of methamphetamine neurotoxicity in the striatum of the mouse brain. Yu J., Allison S., Ibrahim D., Cadet J.L., Angulo J.A., p. 247-253.
• Morphological and biochemical evidence that apomorphine rescues striatal dopamine terminals and prevents methamphetamine toxicity. Battaglia G., Gesi M., Lenzi P., Busceti C.L., Soldani P., Orzi F., et al., p. 254-266.
• Neurokinin receptors modulate the neurochemical actions of cocaine. Noailles P.A., Angulo J.A., p. 267-273.
• Calpain upregulation and neuron death in spinal cord of MPTP-induced parkinsonism in mice. Chera B., Schaecher K.E., Rocchini A., Imam S.Z., Ray S.K., Ali S.F., et al., p. 274-280.
PART V. Drugs of abuse: cocaine, methamphetamine, toulene, alcohol, and nicotine
• Abused inhalants and central reward pathways: electrophysiological and behavioral studies in the rat. Riegel A.C., French E.D., p. 281-291.
• Factors for susceptibility to episode recurrence in spontaneous recurrence of methamphetamine psychosis. Yui K., Ikemoto S., Goto K., p. 292-304.
• Environmental chemical compounds could induce sensitization to drugs of abuse. Duffard R., Evangelista de Duffard A.M., p. 305-313.
• Increased sensitivity in dopamine D(2)-like brain receptors from 2,4-dichlorophenoxyacetic acid (2,4-D)-exposed and amphetamine-challenged rats. Bortolozzi A., Duffard R., Antonelli M., Evangelista de Duffard A.M., p. 314-323.
• Developmental expression of the beta-amyloid precursor protein and heat-shock protein 70 in the cerebral hemisphere region of the rat brain. Lahiri D.K., Nall C., Chen D., Zaphiriou M., Morgan C., Nurnberger J.I., Sr., p. 324-333.
• Alcohol exposure during adulthood induces neuronal and astroglial alterations in the hippocampal CA-1 area. Tagliaferro P., Vega M.D., Evrard S.G., Ramos A.J., Brusco A., p. 334-342.
• Effects of chronic maternal ethanol exposure on hippocampal and striatal morphology in offspring. Ramos A.J., Evrard S.G., Tagliaferro P., Tricarico M.V., Brusco A., p. 343-353.
• Brain regions mediating the discriminative stimulus effects of nicotine in rats. Miyata H., Ando K., Yanagita T., p. 354-363.
• Nicotine reduces the secretion of Alzheimer's beta-amyloid precursor protein containing beta-amyloid peptide in the rat without altering synaptic proteins. Lahiri D.K., Utsuki T., Chen D., Farlow M.R., Shoaib M., Ingram D.K., et al., p. 364-372.
PART VI. MDMA neurotoxicity
• Serotonergic neurotoxicity of MDMA (ecstasy) in the developing rat brain. Meyer J.S., Ali S.F., p. 373-380.
• Striatal postsynaptic ultrastructural alterations following methylenedioxymethamphetamine administration. Fornai F., Gesi M., Lenzi P., Ferrucci M., Pellegrini A., Ruggieri S., et al., p. 381-398.
• Action of MDMA (ecstasy) and its metabolites on arginine vasopressin release. Fallon J.K., Shah D., Kicman A.T., Hutt A.J., Henry J.A., Cowan D.A., et al., p. 399-409.
• Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study. Gough B., Imam S.Z., Blough B., Slikker W., Jr., Ali S.F., p. 410-420.
• Cell-mediated immune response in MDMA users after repeated dose administration: studies in controlled versus noncontrolled settings. Pacifici R., Zuccaro P., Farre M., Pichini S., Di Carlo S., Roset P.N., et al., p. 421-433.
PART VII. Drugs of abuse, imaging brain structure, and function
• Methylphenidate-evoked potentiation of extracellular dopamine in the brain of adolescents with premature birth: correlation with attentional deficit. Rosa Neto P., Lou H., Cumming P., Pryds O., Gjedde A., p. 434-439.
• The competition between endogenous dopamine and radioligands for specific binding to dopamine receptors. Cumming P., Wong D.F., Dannals R.F., Gillings N., Hilton J., Scheffel U., et al., p. 440-450.
PART VIII. GHB, GBL, BD: Behavior, biochemistry, and pharmacokinetics
• Repeated administration of gamma-hydroxybutyric acid (GHB) to mice: assessment of the sedative and rewarding effects of GHB. Itzhak Y., Ali S.F., p. 451-460.
• Enzyme and receptor antagonists for preventing toxicity from the gamma-hydroxybutyric acid precursor 1,4-butanediol in CD-1 mice. Quang L.S., Desai M.C., Kraner J.C., Shannon M.W., Woolf A.D., Maher T.J., p. 461-472.
PART IX. Drugs of abuse: Heroin and opiates - from animal to human
• Cell signaling as a target and underlying mechanism for neurobehavioral teratogenesis. Yanai J., Vatury O., Slotkin T.A., p. 473-478.
• Nitric oxide production and nitric oxide synthase expression in platelets from heroin abusers before and after ultrarapid detoxification. Batista A., Macedo T., Tavares P., Ribeiro C.F., Relvas J., Gomes P., et al., p. 479-486.
• Toxic effects of opioid and stimulant drugs on undifferentiated PC12 cells. Oliveira M.T., Rego A.C., Morgadinho M.T., Macedo T.R., Oliveira C.R., p. 487-496.
• Recombinant mu-delta receptor as a marker of opiate abuse. Dambinova S.A., Izykenova G.A., p. 497-514.
PART X. Perinatal exposure of cocaine and methamphetamine: neurobehavioral and neurochemical outcome
• Neonatal exposure to cocaine: altered dopamine levels in the amygdala and behavioral outcomes in the developing rat. Summavielle T., Magalhaes A., Castro-Vale I., de Sousa L., Tavares M.A., p. 515-521.
• Structural and functional cellular alterations underlying the toxicity of methamphetamine in rat retina and prefrontal cortex. Prudencio C., Abrantes B., Lopes I., Tavares M.A., p. 522-528.
• Postnatal cocaine exposure: effects on behavior of rats in forced swim test. Magalhaes A., Tavares M.A., de Sousa L., p. 529-534.
Cote :
L01527